ADAPTIMMUNE THERAPEUTICS PLC Debt Securities, Available-for-sale, Current
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Debt Securities, Available-for-sale, Current of $0 as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2025-08-13
- 2025-06-30: Debt Securities, Available-for-sale, Current $0.00.
- 2025-03-31: Debt Securities, Available-for-sale, Current $18.51M.
- 2024-12-31: Debt Securities, Available-for-sale, Current $60.47M.
- 2024-09-30: Debt Securities, Available-for-sale, Current $69.35M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2025-03-31 | $18.51M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $60.47M 10-Q · filed 2025-08-13 |
| 2024-09-30 | $69.35M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $2.98M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $2.98M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.95M 10-K · filed 2025-03-24 |
| 2023-09-30 | $71.67M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $127.74M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $45.69M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $96.57M 10-K · filed 2024-03-06 |
| 2022-09-30 | $120.67M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $160.28M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $214.68M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $219.63M 10-K · filed 2023-03-06 |
| 2021-09-30 | $197.20M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $234.92M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $285.51M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $311.33M 10-K · filed 2022-03-14 |
| 2020-09-30 | $321.44M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $296.63M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $110.00M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $39.13M 10-K · filed 2021-02-25 |
| 2019-09-30 | $63.45M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $98.83M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $118.24M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $136.75M 10-K · filed 2020-02-27 |
| 2018-09-30 | $84.65M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $86.72M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $108.46M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $124.22M 10-K · filed 2019-02-27 |
| 2017-09-30 | $86.53M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $80.02M 10-Q · filed 2017-08-03 |